Mason Street Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-11,160
| Closed | -$506K | – | 999 |
|
2020
Q4 | $506K | Sell |
11,160
-45
| -0.4% | -$2.04K | 0.01% | 1166 |
|
2020
Q3 | $308K | Sell |
11,205
-679
| -6% | -$18.7K | 0.01% | 1236 |
|
2020
Q2 | $438K | Buy |
11,884
+967
| +9% | +$35.6K | 0.01% | 1121 |
|
2020
Q1 | $353K | Hold |
10,917
| – | – | 0.01% | 1110 |
|
2019
Q4 | $447K | Buy |
10,917
+294
| +3% | +$12K | 0.01% | 1167 |
|
2019
Q3 | $378K | Buy |
10,623
+350
| +3% | +$12.5K | 0.01% | 1182 |
|
2019
Q2 | $528K | Buy |
10,273
+448
| +5% | +$23K | 0.01% | 1082 |
|
2019
Q1 | $563K | Buy |
9,825
+476
| +5% | +$27.3K | 0.01% | 1091 |
|
2018
Q4 | $392K | Buy |
9,349
+644
| +7% | +$27K | 0.01% | 1124 |
|
2018
Q3 | $657K | Buy |
8,705
+958
| +12% | +$72.3K | 0.01% | 1010 |
|
2018
Q2 | $556K | Buy |
+7,747
| New | +$556K | 0.01% | 1036 |
|